Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 16 of 16 entries
Sorted by: Best Match Show Resources per page
[How drugs affect the kidneys].

Sairaanhoitaja. Sjukskoterskan

Kasanen A.
PMID: 5197047
Sairaanhoitaja. 1969 Sep 25;45(13):656-8.

No abstract available.

Cite
Kasanen A. Lääkkeiden vaikutus munuaisiin. [How drugs affect the kidneys]. Sairaanhoitaja. 1969;45(13):656-8
Kasanen, A. (1969). Lääkkeiden vaikutus munuaisiin. [How drugs affect the kidneys]. Sairaanhoitaja. Sjukskoterskan, 45(13), 656-8.
Kasanen, A. "Lääkkeiden vaikutus munuaisiin." [How drugs affect the kidneys]. Sairaanhoitaja. Sjukskoterskan vol. 45,13 (1969): 656-8.
Kasanen A. Lääkkeiden vaikutus munuaisiin. [How drugs affect the kidneys]. Sairaanhoitaja. 1969 Sep 25;45(13):656-8. Finnish. PMID: 5197047.
Copy Download .nbib Format: NLM
Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infection.

Expert opinion on drug safety

Wyatt CM, Klotman PE.
PMID: 16503748
Expert Opin Drug Saf. 2006 Mar;5(2):275-87. doi: 10.1517/14740338.5.2.275.

The widespread introduction of highly active antiretroviral therapy (HAART) has revolutionised the treatment and course of HIV infection, with complications of chronic HIV infection and HAART playing an increasingly important role in morbidity and mortality. Both HIV infection and...

Cite
Wyatt CM, Klotman PE. Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infection. Expert Opin Drug Saf. 2006;5(2):275-87doi: 10.1517/14740338.5.2.275.
Wyatt, C. M., & Klotman, P. E. (2006). Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infection. Expert opinion on drug safety, 5(2), 275-87. https://doi.org/10.1517/14740338.5.2.275
Wyatt, Christina M, and Klotman, Paul E. "Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infection." Expert opinion on drug safety vol. 5,2 (2006): 275-87. doi: https://doi.org/10.1517/14740338.5.2.275
Wyatt CM, Klotman PE. Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infection. Expert Opin Drug Saf. 2006 Mar;5(2):275-87. doi: 10.1517/14740338.5.2.275. PMID: 16503748.
Copy Download .nbib Format: NLM
The cardiorenal syndrome: should change make us uncomfortable?.

Journal of cardiac failure

Nohria A.
PMID: 22123362
J Card Fail. 2011 Dec;17(12):1001-3. doi: 10.1016/j.cardfail.2011.10.011.

No abstract available.

Cite
Nohria A. The cardiorenal syndrome: should change make us uncomfortable?. J Card Fail. 2011;17(12):1001-3doi: 10.1016/j.cardfail.2011.10.011.
Nohria, A. (2011). The cardiorenal syndrome: should change make us uncomfortable?. Journal of cardiac failure, 17(12), 1001-3. https://doi.org/10.1016/j.cardfail.2011.10.011
Nohria, Anju. "The cardiorenal syndrome: should change make us uncomfortable?." Journal of cardiac failure vol. 17,12 (2011): 1001-3. doi: https://doi.org/10.1016/j.cardfail.2011.10.011
Nohria A. The cardiorenal syndrome: should change make us uncomfortable?. J Card Fail. 2011 Dec;17(12):1001-3. doi: 10.1016/j.cardfail.2011.10.011. PMID: 22123362.
Copy Download .nbib Format: NLM
Renal effects of PPARalpha-agonists.

Minerva urologica e nefrologica = The Italian journal of urology and nephrology

Izzedine H, Launay-Vacher V, Baumelou A, Deray G.
PMID: 15785426
Minerva Urol Nefrol. 2004 Dec;56(4):339-42.

Peroxisome proliferator-activated receptor alpha (PPARalpha) is a member of the large nuclear receptor superfamily. Its main role is to activate genes involved in fatty acid oxidation in the liver, heart, kidney and skeletal muscle. While they are mainly used...

Cite
Izzedine H, Launay-Vacher V, Baumelou A, et al. Renal effects of PPARalpha-agonists. Minerva Urol Nefrol. 2004;56(4):339-42
Izzedine, H., Launay-Vacher, V., Baumelou, A., & Deray, G. (2004). Renal effects of PPARalpha-agonists. Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 56(4), 339-42.
Izzedine, H, et al. "Renal effects of PPARalpha-agonists." Minerva urologica e nefrologica = The Italian journal of urology and nephrology vol. 56,4 (2004): 339-42.
Izzedine H, Launay-Vacher V, Baumelou A, Deray G. Renal effects of PPARalpha-agonists. Minerva Urol Nefrol. 2004 Dec;56(4):339-42. PMID: 15785426.
Copy Download .nbib Format: NLM
Showing 13 to 16 of 16 entries